Quanterix (NASDAQ:QTRX) Issues Quarterly Earnings Results

Quanterix (NASDAQ:QTRX) issued its earnings results on Monday. The company reported ($0.36) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.13), Zacks reports. Quanterix had a negative return on equity of 18.41% and a negative net margin of 56.04%. Quanterix updated its FY 2025 guidance to EPS.

Quanterix Stock Performance

QTRX traded up $0.18 during trading on Monday, reaching $5.12. The stock had a trading volume of 373,037 shares, compared to its average volume of 719,550. The business has a 50-day moving average of $5.32 and a 200-day moving average of $5.48. Quanterix has a one year low of $4.05 and a one year high of $15.67. The stock has a market cap of $237.79 million, a PE ratio of -2.81 and a beta of 1.12.

Wall Street Analyst Weigh In

A number of research firms have recently commented on QTRX. Canaccord Genuity Group restated a “hold” rating and issued a $5.00 price objective (down from $12.00) on shares of Quanterix in a research report on Monday, August 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quanterix in a research report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $11.75.

Hedge Funds Weigh In On Quanterix

Institutional investors have recently modified their holdings of the company. HUB Investment Partners LLC purchased a new position in shares of Quanterix during the 2nd quarter valued at about $81,000. Brevan Howard Capital Management LP bought a new position in Quanterix during the second quarter valued at approximately $96,000. State of Wyoming raised its stake in shares of Quanterix by 105.3% during the second quarter. State of Wyoming now owns 14,814 shares of the company’s stock worth $99,000 after acquiring an additional 7,599 shares in the last quarter. Quantbot Technologies LP lifted its holdings in shares of Quanterix by 182.7% in the 2nd quarter. Quantbot Technologies LP now owns 31,864 shares of the company’s stock worth $212,000 after acquiring an additional 20,592 shares during the last quarter. Finally, Quantinno Capital Management LP lifted its holdings in shares of Quanterix by 307.4% in the 2nd quarter. Quantinno Capital Management LP now owns 41,964 shares of the company’s stock worth $279,000 after acquiring an additional 31,664 shares during the last quarter. 86.48% of the stock is currently owned by institutional investors.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.